iVeena Delivery Systems said earlier this month that it finished a pilot trial for its IVMED-10 bioerodible implant designed to treat pain and inflammation after cataract surgery.
Placed during cataract surgery, the sustained-release implant delivers dexamethasone for two weeks from the lens capsule.
Get the full story at our sister site, Drug Delivery Business News.